Verition Fund Management
MDT icon

Verition Fund Management’s Medtronic MDT Stock Holding History

Verition Fund Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
17,200
-7,500
-30% -$718K 0.01% 1158
2025
Q4 		$2.37M Sell
24,700
-53,600
-68% -$5.21M 0.01% 1449
2025
Q3 		$7.46M Buy
78,300
+15,200
+24% +$1.4M 0.03% 749
2025
Q2 		$5.5M Buy
63,100
+16,900
+37% +$1.43M 0.02% 1008
2025
Q1 		$4.15M Sell
46,200
-9,500
-17% -$850K 0.02% 988
2024
Q4 		$4.45M Sell
55,700
-14,500
-21% -$1.26M 0.02% 972
2024
Q3 		$6.32M Sell
70,200
-5,200
-7% -$437K 0.03% 685
2024
Q2 		$5.93M Buy
75,400
+13,800
+22% +$1.13M 0.03% 622
2024
Q1 		$5.37M Buy
61,600
+44,600
+262% +$3.81M 0.04% 627
2023
Q4 		$1.4M Buy
17,000
+8,100
+91% +$617K 0.01% 1016
2023
Q3 		$697K Buy
+8,900
New +$745K 0.01% 1259
2022
Q4 		– Sell
-8,400
Closed -$678K – 2502
2022
Q3 		$678K Buy
+8,400
New +$755K 0.01% 1677
2022
Q2 		– Sell
-16,600
Closed -$1.84M – 2791
2022
Q1 		$1.84M Buy
16,600
+5,900
+55% +$623K 0.02% 1037
2021
Q4 		$1.11M Buy
+10,700
New +$1.24M 0.01% 1235

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management's MDT Position: Q1 2026 in Review

Verition Fund Management reduced its Medtronic (MDT) stake by 70% in Q1 2026, selling an estimated $2.56M and leaving 11,186 shares worth $969K. The position accounts for 0.01% of the portfolio, ranked #1317.

Verition Fund Management first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $20.3M in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Verition Fund Management held 11,186 shares of Medtronic worth $969K as of Q1 2026.
  • Verition Fund Management sold 26,714 Medtronic shares in Q1 2026, an estimated $2.56M.
  • Medtronic made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1317 holding.
  • Verition Fund Management first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
  • Verition Fund Management's Medtronic position peaked at $20.3M in Q2 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.